LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has begun a strategic evaluation process with Vertice Seguros, a Venezuelan insurance provider, to explore integrating insurance products with its digital healthcare platforms. The initiative aims to assess how life and health insurance offerings from Vertice Seguros could become accessible through LataMed AI’s telehealth infrastructure, while allowing Vertice Seguros clients to access LataMed AI’s healthcare technology services, including telehealth, care coordination, analytics, and AI-enabled solutions.
The proposed collaboration could create complementary commercial opportunities for both organizations by expanding customer reach, increasing healthcare accessibility, enhancing patient engagement, and supporting broader adoption of technology-enabled healthcare and financial protection solutions throughout Latin America. Management believes that healthcare accessibility extends beyond care delivery to include financial protection solutions, and that combining technology services with insurance may support greater patient engagement and improve long-term outcomes in underserved markets.
Preliminary operational, technical, and commercial evaluation activities are underway to assess user onboarding processes, platform integration requirements, operational workflows, regulatory considerations, and potential service deployment models. These activities are intended to determine the feasibility and scalability of a broader strategic relationship between the parties.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "Our vision is to create a more connected healthcare ecosystem where technology, care delivery, and financial protection solutions work together to improve accessibility and outcomes. We believe this evaluation process with Vertice Seguros represents an opportunity to explore how healthcare technology services and insurance solutions can be combined within a unified digital platform designed to serve patients, providers, and healthcare consumers throughout Latin America."
The evaluation aligns with LataMed AI’s broader strategy of developing an integrated healthcare ecosystem combining artificial intelligence, telehealth infrastructure, healthcare analytics, care coordination, pharmacy connectivity, emergency response capabilities, and digital healthcare services to improve access in Latin America. The Company and Vertice Seguros are currently conducting technical, operational, and commercial evaluations, and any definitive arrangement would remain subject to successful completion of the evaluation process, negotiation of final terms, regulatory considerations, and execution of definitive agreements. LataMed AI intends to provide additional updates as material developments occur.
For additional information, visit https://latamed.ai and review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
